CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer

CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer
复制标题

CXCL12/CXCR4 轴靶向双功能纳米药物递送系统对抗卵巢癌

DOI:
10.2147/ijn.s257527
复制
发表时间:
2020-08
影响因子:
8
通讯作者:
Xie Hongjuan
Xie Hongjuan
中科院分区:
医学2区
文献类型:
--
作者:
Xue Jiyang;Li Ruixiang;Gao Dingding;Chen Fenghua;Xie Hongjuan

文献摘要

参考文献

相似文献

前言卵巢癌的传统化疗因耐药和全身副作用而受到限制。尽管已经设计了各种靶向给药策略来增强肿瘤部位的药物积聚,但简单的改进
Introduction Traditional chemotherapy for ovarian cancer is limited due to drug resistance and systemic side effects. Although various targeted drug delivery strategies have been designed to enhance drug accumulation at the tumor site, simply improvement
DOI: 10.1016/j.canlet.2012.02.035
发表时间: 2012-09-28
期刊: CANCER LETTERS
影响因子: 9.7
作者:
Li, Xuqi;Ma, Qingyong;Xu, Qinhong;Liu, Han;Lei, Jianjun;Duan, Wanxing;Bhat, Kruttika;Wang, Fengfei;Wu, Erxi;Wang, Zheng
通讯作者: Wang, Zheng
DOI: 10.1891/9780826121646.0002
发表时间: 2018-09
期刊: Cancer Rehabilitation
影响因子: --
作者:
K. Miller;R. Siegel;R. Khan;A. Jemal
通讯作者: K. Miller;R. Siegel;R. Khan;A. Jemal
DOI: 10.1002/mc.22645
发表时间: 2017-08
影响因子: 4.6
作者:
Ning Zheng;Jiahang Chen;Tao Li;Weiqun Liu;Jian Liu;Hongning Chen;Jichuang Wang;L. Jia
通讯作者: Ning Zheng;Jiahang Chen;Tao Li;Weiqun Liu;Jian Liu;Hongning Chen;Jichuang Wang;L. Jia
DOI: 10.3727/096504015x14343704124430
发表时间: 2014
期刊: Oncology research
影响因子: 3.1
作者:
Guo Q;Gao BL;Zhang XJ;Liu GC;Xu F;Fan QY;Zhang SJ;Yang B;Wu XH
通讯作者: Wu XH
DOI: 10.1016/j.apsb.2016.01.007
发表时间: 2016-07
期刊: Acta pharmaceutica Sinica. B
影响因子: --
作者:
Hong EJ;Choi DG;Shim MS
通讯作者: Shim MS